Cell signaling

Afamelanotide

Melanotan I / Melanotan 1 / Scenesse

Peptide length
13 amino acids

Modified alpha-MSH analog

Evidence availableEvidence for a defined medicine

Open the sources to check how the studies were done and what they can support.

A melanocortin analog studied in erythropoietic protoporphyria and used in a regulated implant formulation.

Family
Melanocortin analog
Research target
Melanocortin 1 receptor
Molecular form
Modified alpha-MSH analog

What to know about the research

Controlled EPP research concerns phototoxicity and quality of life in a defined disease population, not unrestricted cosmetic tanning.

Check the exact compound

Afamelanotide, melanotan II and bremelanotide are different molecules. A research preparation is not equivalent to the regulated implant.

FOLLOW THE EVIDENCE

What supports this entry?

The reference list is available. A statement-by-statement source check has not been completed for this entry.

These are selected references, not a complete review of the literature. Source checks were assisted by AI and have not received independent expert review.

Research stage, study quality and regulatory status answer different questions. A study card does not establish treatment benefit or approval.

No study details have been extracted for this exact entry yet. This does not mean that no studies exist. Open the references and check the exact material.

How we prepare and correct these entries

Read the research in context

Keep your Afamelanotide research together.

Get the compound summary, evidence notes, source links, and a reading checklist in one research pack.

Get my research pack